Search results for "Prostate Cancer"
Prostate cancer treatment options result in similar 15-year outcomes
Functional outcomes among men undergoing prostatectomy or radiotherapy for prostate cancer differed at two and five years of follow-up, but significant differences were no longer present by 15 years, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/4.htm
5 Feb 2013
Research model supports strategies that increase PSA screening interval and age-specific thresholds for biopsy
Using higher thresholds for biopsy referral for older men and screening men with initially low prostate-specific antigen (PSA) levels less frequently seem to reduce harms of screening while preserving lives, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/5.htm
5 Feb 2013
Emphasize potential prostate biopsy and cancer treatment outcomes when discussing risks, benefits of PSA testing
One-third of men age 65 and older with abnormal prostate-specific antigen (PSA) levels elect to have a prostate biopsy, yet once cancer is detected most men undergo immediate treatment regardless of advanced age and multiple comorbidities, a study found.
https://immattersacp.org/weekly/archives/2013/04/23/5.htm
23 Apr 2013
Age, comorbidity should inform decisions on how to treat low- or intermediate- risk prostate cancer
Older men with prostate cancer and multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this when deciding between conservative management and aggressive treatment for low- or intermediate-risk disease, a study concluded.
https://immattersacp.org/weekly/archives/2013/05/21/2.htm
21 May 2013
Treatment for prostate symptoms doesn't appear to increase risk for advanced prostate cancer
Treating prostate symptoms with 5α-reductase inhibitors (5-ARIs) does not appear to increase risk for advanced prostate cancer, a new study indicates.
https://immattersacp.org/weekly/archives/2013/06/25/1.htm
25 Jun 2013
Decision aids increased knowledge about prostate cancer but didn't affect screening rates
Decision aids improved participants' informed decision making about prostate cancer screening but did not change the actual screening rates, a study found.
https://immattersacp.org/weekly/archives/2013/08/06/2.htm
6 Aug 2013
Communication skills vital to cancer conversations
Cancer patients want information, but not in a way that makes them lose hope. Effective shared decision making and risk communication strategies can help.
https://immattersacp.org/archives/2013/09/communication.htm
1 Sep 2013
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013
Look for reasons if patients refuse advice
Refusal can be frustrating for physicians, who likely see their medical advice as contributing toward healing and improving quality of life. But patients reserve the right to make informed decisions about their care, even if these decisions run counter to what's been recommended.
https://immattersacp.org/archives/2014/02/informed-refusal.htm
1 Feb 2014
Surgery performs better than radiotherapy for non-metastatic prostate cancer
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
https://immattersacp.org/weekly/archives/2014/03/11/5.htm
11 Mar 2014